The plight of ADHD and Depression patients seeking medical cannabis in Germany, with Maximillian Plenert

Published: Nov. 7, 2019, 5:42 p.m.

The plight of ADHD and Depression patients seeking medical cannabis in Germany, with Maximillian Plenert. We spoke with speaker of the German cannabis patients' association Maximillian Plenert. He explained that recent law changes have allowed for health insurance coverage of cannabis medicines, but that companies dont want to cover them for conditions like ADHD or depression. He says 1 gram of cannabis from a pharmacy costs more than 20 Euro (22 USD, 32 AUD), so without insurance coverage many patients turn back to the black market. Adding to the challenges faces by patients, many doctors don't want to prescribe cannabis for these conditions. Maximilian also runs a patients hotline that is constantly taking calls from frustrated ADHD patients who can't get access to or afford the cannabis medicines that help them to function well. He says ADHD patients are the largest homogenous group of patients and suggests the possibility of bringing many of together to "crash into the system" and raise awareness of their terrible struggles to access and/or afford cannabis medicines.